Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

27

Revenue 2017

Gilenya

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gilenya was produced by Novartis.

Novartis buys rights to GSK's Arzerra in MS for $1bn

Novartis buys rights to GSK's Arzerra in MS for $1bn s oral drug Tecfidera (dimethyl glutamate) and Novartis' own Gilenya (fingolimod).

Novartis sales dip, but all eyes are on Entresto

Novartis sales dip, but all eyes are on Entresto Meanwhile, there were other bright spots in Novartis' pharma portfolio, including oral multiple sclerosis therapy Gilenya (fingolimod) which grew 26% to $700m in the quarter and leukaemia therapy Tasigna (nilotinib), up

Novartis wins partial reprieve for Gilenya in Germany

Novartis wins partial reprieve for Gilenya in Germany Germany's drug pricing watchdog is now recommending Novartis' multiple sclerosis pill Gilenya (fingolimod) to treat more patients after re-assessing its data. . ... The new analyses of Novartis' TRANSFORMS study also showed that Gilenya has advantages

Novartis heart drug may see novel pricing plan

Novartis heart drug may see novel pricing plan Novartis already has a pricing system in place in the US using its multiple sclerosis drug Gilenya (fingolimod), where payment is structured out clinical outcomes, rather than a set per-pill

2015 set to be a transitional year for Merck KGaA's health unit

2015 set to be a transitional year for Merck KGaA's health unit Rebif sales fell nearly 16% to 430m as the MS market continues to switch towards oral therapies such as Biogen Idec's Tecfidera (dimethyl glutamate) and Novartis' Gilenya (fingolimod).

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page

For those who can imagine better, Page & Page is home to meaningful encounters of a marketing, communication and creative kind:...

Latest intelligence

The big issue
Whether you want to lead or follow, you need to understand the elephant in the C-suite...
INFOGRAPHIC 02: The Importance of clinical study websites
Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
Working with, Advocating for, and Empowering Patients
A holistic view of how to work with patients virtually...

Infographics